Includes Special Report on Global COVID-19 Response and
Commitment to Diversity & Inclusion
LAVAL, QC, Sept. 23, 2020 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company")
today released its annual Corporate Social Responsibility (CSR)
Report, highlighting the Company's ongoing commitment to
responsible, ethical and sustainable operations in 2019. In
addition to outlining initiatives and key performance indicators in
2019, the report features an early look at 2020 efforts, including
the Company's COVID-19 response efforts in the first half of 2020
and its Diversity & Inclusion (D&I) initiatives.
"Now more than ever, we recognize the increased importance of
corporate citizenship in creating an environment where our
employees, our customers, our partners and our communities can
thrive," said Joseph C. Papa,
chairman and CEO, Bausch Health. "As
we continue to improve sustainability and raise the bar on our
ethical, social and operational standards, we are furthering our
mission to improve lives and advance global health."
The 2019 CSR report also includes other global efforts in the
Company's five key commitment areas: operate with integrity;
respect the environment; advance global health and patient care;
improve communities; and support employee growth and well-being.
Additionally, the report includes the highlights of charitable
giving efforts directed by the Bausch Foundation, as detailed in
the Bausch Foundation Inaugural Activity Report released earlier
this month.
2019 CSR highlights include:
- Reductions in energy usage, water usage, waste production and
carbon emissions at Bausch Health facilities
-
- Establishment of Energy Efficiency Group (EEG) to analyze and
improve energy consumption globally
- Installation of new nitrogen-generating plant in Waterford, Ireland, reducing future carbon
dioxide emissions by nearly 200 tons per year
- Collaborations, financial contributions and product donations
to global charitable health organizations and patient advocacy
groups
- Continued commitment to patient access and responsible pricing,
including that the average annual price increase for branded
prescription products would be set at no greater than single
digits
- Continuing to support provider education, research grants and
charitable organizations devoted to improving patient care and
quality of life, and advancing the safety and effectiveness of
healthcare products
The full report can be viewed in the Responsibility section of
Bausch Health's website at
https://www.bauschhealth.com/responsibility.
About Bausch Health
Bausch Health Companies
Inc. (NYSE/TSX: BHC) is a global company whose mission is to
improve people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Forward-looking Statements
This news
release may contain forward-looking statements, which may generally
be identified by the use of the words
"anticipates," "expects," "intends," "plans," "should," "could," "would," "may,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, the risks and uncertainties discussed in Bausch
Health's most recent annual report on Form 10-K and detailed from
time to time in Bausch Health's other filings with the U.S.
Securities and Exchange Commission and the Canadian Securities
Administrators, which factors are incorporated herein by reference.
They also include, but are not limited to, risks and uncertainties
caused by or relating to the evolving COVID-19 pandemic, and the
fear of that pandemic and its potential effects, the severity,
duration and future impact of which are highly uncertain and cannot
be predicted, and which may have a material adverse impact on
Bausch Health, including but not limited to its project development
timelines, and costs (which may increase). Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch Health undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-releases-annual-corporate-social-responsibility-report-301136096.html
SOURCE Bausch Health Companies Inc.